This event, the third in the Koch Institute's with/in/sight lecture series, featured three expert perspectives on cancer stem cells and metastatic disease. Speakers were Tyler Jacks, Director of the Koch Institute for Integrative Cancer Research; Jonathan Pachter, Head of Research at Verastem, Inc.; and Perry Nisen, Senior Vice President of Cancer Research at GlaxoSmithKline.
Watch a video of Tyler Jacks' presentation:
Or browse through photos from the event:
Learn more about the Koch Institute's with/in/sight series and register for the next event at: http://ki.mit.edu/news/events/withinsight.